Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line
- 31 January 2005
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 93 (1) , 25-34
- https://doi.org/10.1016/j.jsbmb.2004.11.005
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast CancerNew England Journal of Medicine, 2004
- Phase III Study of Letrozole Versus Tamoxifen as First-Line Therapy of Advanced Breast Cancer in Postmenopausal Women: Analysis of Survival and Update of Efficacy From the International Letrozole Breast Cancer GroupJournal of Clinical Oncology, 2003
- Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trialThe Lancet, 2002
- Local uptake and synthesis of oestrone in normal and malignant postmenopausal breast tissuesThe Journal of Steroid Biochemistry and Molecular Biology, 2002
- Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinomaCancer, 2001
- DHEA and Its Transformation into Androgens and Estrogens in Peripheral Target Tissues: IntracrinologyFrontiers in Neuroendocrinology, 2001
- Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer GroupJournal of Clinical Oncology, 2001
- Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized TrialJournal of Clinical Oncology, 2000
- Regulation of Aromatase Activity Within the BreastThe Journal of Steroid Biochemistry and Molecular Biology, 1997
- in situ oestrone synthesis in normal breast and breast tumour tissues: Effect of treatment with 4‐hydroxyandrostenedioneInternational Journal of Cancer, 1989